Loading clinical trials...
Loading clinical trials...
EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the like...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Our Lady of the Lake Hospital
NCT07216209 · Lung Cancer - Non Small Cell
NCT06889467 · Non Small Cell Lung Cancer, Non Small Cell Lung Cancer (NSCLC), and more
NCT06786468 · Lung Cancer - Non Small Cell, Lung Cancer (NSCLC)
NCT06621147 · Lung Cancer - Non Small Cell
NCT01532089 · EGFR Exon 19 Deletion Mutation, EGFR NP_005219.2:p.L858R, and more
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions